Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 147 (RN7SKP147) is a **pseudogene**, meaning it is a genomic DNA sequence similar to the functional RN7SK gene but typically non-functional and does not produce a functional RNA or protein product. Pseudogenes like RN7SKP147 do not have a recognized role as molecular targets, receptors, enzymes, or transporters and are considered non-coding, generally without known biological or therapeutic relevance. The functional counterpart, RN7SK, is an abundant small nuclear RNA involved in the regulation of RNA polymerase II transcription by controlling the activity of the positive transcription elongation factor b (P-TEFb) complex. However, RN7SKP147 itself is not a receptor, enzyme, or recognized therapeutic target, and there is no evidence of its involvement in known molecular or disease pathways[1][2][3][4]. **Clarification on inaccuracies or issues:** - RN7SKP147 is a **pseudogene**, not a gene coding for a functional RNA, protein, or receptor. - No evidence supports RN7SKP147 as a therapeutic target or molecular entity with functional, biological, or disease-associated roles. - If the original intent was to query the **functional small nuclear RNA RN7SK** (not the pseudogene), it should be referred to as “RN7SK small nuclear RNA” or simply “7SK RNA.” **Summary of conventions:** - “RN7SK pseudogene 147” should not be considered as a canonical, targeted molecular entity. - There are no associated drugs, mechanisms of action, biomarkers, or disease roles for RN7SKP147. If you require information on the **functional RN7SK small nuclear RNA**, please clarify, as RN7SK has substantial importance in transcriptional regulation and disease relevance[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 147 (RN7SKP147).